Craig Millian
Chief Executive Officer at HLS THERAPEUTICS INC.
Net worth: 64 616 $ as of 31/03/2024
Profile
Craig Millian is currently the Chief Executive Officer & Director at HLS Therapeutics, Inc. Prior to this, he was the Chief Operating Officer at Corbus Pharmaceuticals Holdings, Inc. from 2021 to 2023.
He was also the Senior Vice President-Neurology & Immunology at EMD Serono, Inc. from 2016 to 2018.
Before that, he worked as the Vice President-Commercial at Vertex Pharmaceuticals, Inc. Mr. Millian has an undergraduate degree from the University of Pennsylvania and an MBA from New York University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
13/02/2023 | 900 ( 0.01% ) | 35 316 $ | 31/03/2024 | |
HLS THERAPEUTICS, INC.
0.03% | 16/11/2023 | 10,000 ( 0.03% ) | 29 300 $ | 31/03/2024 |
Craig Millian active positions
Companies | Position | Start |
---|---|---|
HLS THERAPEUTICS INC. | Chief Executive Officer | 01/05/2023 |
Former positions of Craig Millian
Companies | Position | End |
---|---|---|
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Chief Operating Officer | 14/04/2023 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01/12/2018 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Training of Craig Millian
University of Pennsylvania | Undergraduate Degree |
New York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
HLS THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Craig Millian